Glymphatic Dysfunction in Parkinson's Disease: A Systematic Review and Meta‐Analysis of Neuroimaging Studies
Movement Disorders Clinical Practice · 2026-02 · 13 (2) · 331-343
DOI: 10.1002/mdc3.70296 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Movement Disorders Clinical Practice, online erschienen am 16.08.2025. Verfasst von Shahryar Rajai Firouzabadi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Student Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Parkinson Disease, Glymphatic System, Neuroimaging. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Parkinson's disease (PD) is a neurodegenerative disorder marked by motor and non‐motor symptoms. Impaired glymphatic clearance, which eliminates neurotoxic proteins, may contribute to PD pathogenesis. MRI techniques including Diffusion Tensor Imaging‐Along the Perivascular Space (DTI‐ALPS) and assessment of Enlarged Perivascular Spaces (EPVS) are used to evaluate glymphatic function.
Objectives
Assessment of glymphatic function in PD and its potential as an imaging biomarker.
Methods
A systematic search of Web of Science, Scopus, and PubMed was conducted on October 27, 2024, for observational MRI studies evaluating glymphatic function in PD. Meta‐analyses compared glymphatic indices between people with PD (PwPD) and healthy controls (HCs). Associations with clinical outcomes and participant characteristics were examined using effect‐direction plots and meta‐correlations.
Results
Thirty‐five studies involving 4224 PwPD and 1287 HCs were included. PwPD had lower DTI‐ALPS (SMD = −0.97; 95% CI: −1.42, −0.52; p < 0.01; I 2 = 91%; k = 15), higher EPVS numbers (SMD = 1.05; 95% CI: 0.37, 1.73; I 2 = 94%; k = 9), and higher EPVS volumes (SMD = 1.08; 95% CI: 0.67, 1.50; I 2 = 64%; k = 4) compared to HCs. Glymphatic dysfunction correlated with motor symptom severity (DTI‐ALPS: Z ‐correlation = −0.29; EPVS number: Z ‐correlation = 0.39). It was not associated with psychiatric symptoms and sex, while associations with global cognition and sleep disturbances were conflicting.
Conclusions
Glymphatic dysfunction is a prominent feature of PD and correlates with motor symptom severity, supporting its potential as a biomarker or potential therapeutic target. Variability in measurement techniques and inconsistent findings on non‐motor symptoms highlight the need for further research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Student Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Neuroscience Research Center, Iran University of Medical Sciences, Tehran, Iran.
- Student Research Committee, Alborz University of Medical Science, Karaj, Iran.
- Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
ORCID-Profile: Shahryar Rajai Firouzabadi, Ida Mohammadi, Aryan Aarabi, Soroush Oraee, Sana Mohammad Soltani, Mehri Salari
Zitieren
APA
Rajai Firouzabadi, S., Mohammadi, I., Aghajanian, S., Aarabi, A., Oraee, S., Soltani, S. M., Mehrpour, A., & Salari, M. (2026). Glymphatic Dysfunction in Parkinson's Disease: A Systematic Review and Meta‐Analysis of Neuroimaging Studies. Movement Disorders Clinical Practice, 13(2), 331-343. https://doi.org/10.1002/mdc3.70296
Vancouver
Rajai Firouzabadi S, Mohammadi I, Aghajanian S, Aarabi A, Oraee S, Soltani SM, et al. Glymphatic Dysfunction in Parkinson's Disease: A Systematic Review and Meta‐Analysis of Neuroimaging Studies. Movement Disorders Clinical Practice. 2026;13(2):331-343. doi:10.1002/mdc3.70296
BibTeX
@article{RajaiFirouzabadi2026,
author = {Rajai Firouzabadi, Shahryar and Mohammadi, Ida and Aghajanian, Sepehr and Aarabi, Aryan and Oraee, Soroush and Soltani, Sana Mohammad and Mehrpour, Amirhossein and Salari, Mehri},
title = {Glymphatic Dysfunction in Parkinson's Disease: A Systematic Review and Meta‐Analysis of Neuroimaging Studies},
journal = {Movement Disorders Clinical Practice},
year = {2026},
volume = {13},
number = {2},
pages = {331--343},
doi = {10.1002/mdc3.70296}
}
EUVIMED